Updated Cochrane Review Assesses COVID-19 Rapid Test Accuracy
The review shows that rapid antigen tests are better at correctly identifying cases of COVID-19 in people with symptoms than in people without symptoms.
Read More
Search Results for: point-of-care testing
PixCell Medical Acquired by Soulbrain Holdings
South Korea-based Soulbrain Holdings has acquired all controlling PixCell shares, making Soulbrain the majority shareholder of PixCell Medical.
Read More
Sense Raises $50M to Accelerate Launch of Covid-19 Molecular Test
Sense Biodetection has raised a $50 million Series B investment to advance commercialization of its Veros covid-19 product and continue development of a portfolio of instrument-free, rapid molecular tests.
Read More
RADx Expands Covid-19 Home and POC Testing, Wastewater Surveillance
NIH announced three new contracts and one new award to an existing contract for scale-up and manufacturing of novel covid-19 testing technologies.
Read More
Qorvo Awarded $24.4M NIH Contract to Scale POC Covid-19 Antigen Testing
The NIH contract through RADx helps advance the production and market launch of the Qorvo Omnia diagnostic test platform.
Read More